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To mark the 15th anniversary of Nature Methods, we asked scientists from across diverse fields of 
basic biology research for their views on the most exciting and essential methodological 
challenges that their communities are poised to tackle in the near future.
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Credit: Andrew LaNoue
Polina Anikeeva: Neural engineering has benefitted from decades of innovation in micro- 
and nano-electronics, photonics, materials science, chemistry and synthetic biology. Our 
current ability to integrate these fields with each other and with neuroscience, however, pales 
in comparison with the scale and complexity of neuronal signaling. Understanding the 
nervous system in the context of health and disease will demand a paradigm shift, from 
refinement of individual device components to integration of multiple signaling capabilities, 
to address the richness of communication within neural circuits. Such a paradigm shift 
highlights the need for fluid exchange of ideas between the fields and demands 
understanding of fundamental physical principles at the core of each technology.
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Credit: Justin Knight
Edward Boyden: Over the last few decades, we have seen the invention of new 
technologies for imaging brain activity, controlling brain activity, and mapping the 
molecular composition and wiring of the brain. An important methodological challenge will 
be to optimize these technologies and incorporate them into a single workflow, so that 
scientists can systematically investigate how the molecular composition and wiring of the 
brain yields its emergent dynamics, which in turn generates behavior and pathology. For 
example, experimental workflows that enable imaging activity throughout a brain circuit, 
then perturbing its dynamics, and finally mapping the molecules and wiring throughout, may 
yield new insights into the mechanisms underlying complex brain functions and 
dysfunctions.
Anikeeva et al. Page 5
Nat Methods. Author manuscript; available in PMC 2020 March 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Clifford Brangwynne: We have a detailed understanding of the conditions under which 
distinct states of non-living matter form, codified in phase diagrams that reflect underlying 
thermodynamic driving forces. Can we achieve a similar quantitative understanding of 
liquid–liquid phase separation within living cells? To truly understand intracellular self-
assembly, and its functional and pathological dysregulation in devastating diseases, the 
answer needs to be yes. New technologies are needed to probe and engineer intracellular 
phase behavior, and should interface with deep proteomics, metabolomics and genomics 
readouts of biological function. These technologies will also elucidate non-equilibrium 
driving forces within the complex intracellular milieu, and provide the foundation for a 
rigorous understanding of living matter.
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Credit: Matt Staley, HHMI/Janelia
Ibrahim I. Cissé: To detect a single fluorescent molecule, it must either be dilute or one 
must turn off any other nearby fluorescent molecule. Although the ability to localize 
individual fluorophores is advantageous and has led to development of super-resolution 
fluorescence microscopy, an implication of needing sparse fluorescent molecules is the 
concentration limit of a few nano-molar or less that it imposes. Practically, this means that, 
at molecular resolution, live-cell fluorescent microscopes only capture the more strongly 
interacting biomolecules, and are blind to most assemblies of weaker affinities. However, the 
growing appreciation for biomolecular condensates and in vivo phase transitions will likely 
force us to come up with clever ways to unveil the blind spots of in vivo single-molecule 
microscopy.
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Oliver Fiehn: Metabolomics has become an integral cornerstone of biological research. 
Biological interpretations rely on accurate identification of metabolites. Yet, currently, 
compound annotations lack confidence scoring; this needs to change! Data reports should 
become more harmonized, with cloud processing for large data sets and kits of internal 
standards to assess metabolite levels. Even in-depth untargeted discovery assays should 
become cheaper and use fast-turnaround standardized protocols. Data needs to become 
findable, accessible, interoperable and re-usable for large-scale analyses. Metabolome 
atlases of compound levels in organs and cells are needed to compare individual studies 
against animal models and human population health data. Eventually, the community should 
tackle the biggest bottleneck: interpreting metabolomics data sets by extending database 
queries towards automatic literature text mining.
Anikeeva et al. Page 8
Nat Methods. Author manuscript; available in PMC 2020 March 16.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Credit: Mary Zhu
Petra Fromme: Biological processes are highly dynamic, but most biomolecular structure 
determination approaches only show a static picture. X-ray-free electron lasers (XFELs) 
have revolutionized structural biology with femtosecond pulses: structures can be 
determined before destruction takes place, enabling the discovery of the dynamics of 
biomolecular reactions ‘on the fly’. However, access to XFELs is limited, with only five 
facilities in the world. Compact XFELs, which aim to shrink XFELs from 1 mile to 30 feet, 
could bring XFEL technology to the laboratory scale, opening the field to the broad 
scientific community. Combined with ultrafast spectroscopy, this will enable the 
determination of the dynamics of molecular and electronic structural transitions 
simultaneously, in real time, in the future.
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Credit: Annie Tong, Sinai Health System
Anne-Claude Gingras: Proteomics research is currently undergoing a burst of exciting 
technical developments, in terms of improving throughput, quantification and the ability to 
analyze very small samples by mass spectrometry. These improvements are already being 
applied to profile protein abundance, but they can also be employed in functional 
proteomics. Coupled with, for example, CRISPR technologies and advances in protein 
labeling and crosslinking techniques, advanced proteomics methods will provide fine details 
of cellular organization, as well as of changes in the association, localization and functions 
of proteins following perturbations. This will require the acquisition of multi-faceted 
datasets, and one of the next challenges will be to develop tools to facilitate their 
visualization and re-use by the broader scientific community.
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Credit: Anna Greene
Casey S. Greene: We are generating data at an unprecedented scale and at levels of 
resolution ranging from environmental sensors to molecular profiling of individual cells. It 
can be tempting to search through large-scale datasets to identify results that support 
existing notions. A near-term challenge is to develop techniques that integrate data to 
illuminate under-studied processes or reveal relationships that are at odds with our 
expectations. Uniting machine learning methods with representations of biomedical 
knowledge that account for the complexity of living systems will be critical to designing 
computational techniques that can overturn our existing understanding and sidestep 
confirmation bias in this era of abundant data.
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Credit: Institut Curie
Edith Heard: Thanks to revolutionary chromosome conformation capture and imaging 
technologies, we are attaining an unprecedented understanding of genome architecture. The 
structures of many of the protein complexes that sculpt, read or duplicate the genome have 
been characterized at the atomic level, and the CRIPSR–Cas9 genetic engineering revolution 
has helped dissect their functions. These technologies provide profound insights into how 
genome structure relates to genome regulation and gene expression. The main technological 
challenge today is to follow the dynamics of genome folding and function over time in living 
cells, integrating imaging and genomic data. We also have to address the behavior and role 
of the repetitive portion of the genome, which may dictate many of its architectural and 
regulatory features. The repeat fraction of the genome has been somewhat of a blind spot for 
the analysis of genome architecture, yet it may contain key architectural and regulatory 
features.
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Stefan W. Hell: Now that the ultimate resolution limit in fluorescence microscopy—that is, 
3D resolution of the size scale of a molecule—has been reached with MINFLUX, we should 
seriously think beyond fluorescence. Coming up with molecular signals that are as specific 
as fluorescence but do not require labeling with reporter molecules; that would be 
something.
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Credit: Eileen Barroso
Elizabeth Hillman: The latest microscopes are revealing the inner workings of living 
organisms like never before: dynamics of motion, high-speed signaling, connectivity, and 
molecular and genetic identity, all in the context of function. Seeing is believing, and what 
used to be inferred can now be directly observed. However, better ways to extract 
quantitative information from these datasets are urgently needed. Brilliant biologists with 
novel specimens need both new expertise and accessible analysis tools to move beyond 
beautiful visualizations to find patterns, trends and answers. Artificial intelligence will 
surely help, but deeper interdisciplinary training of our next generation of life scientists will 
also be essential.
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Grant Jay Jensen: The history of cell biology has been punctuated by major advances in 
imaging technology. Cryo-EM imaging methods have recently enjoyed an amazing 
‘resolution revolution’. In the future, the range of samples that can be imaged will expand to 
both much smaller and much larger targets. For imaging macromolecules, electrons have 
profound advantages over X-rays in that they can be focused to high resolution, revealing 
phases as well as amplitudes. Because of this, and because imaging in 3D is better than 2D, 
the way of the future will be to image macromolecules using cryoelectron tomography. 
Eventually, this will be true across scales and context from crystals of small purified proteins 
to enormous macromolecular complexes inside tissues, but there are formidable technical 
challenges to be overcome in sample preparation, instrumentation and analysis.
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Rachel Karchin: Cancer researchers are working with high-dimensional data: genomic, 
transcriptomic, proteomic and epigenomic, from bulk sequencing to single-cell sequencing 
of tens of thousands of cells. New imaging technologies will provide 2D and 3D views of 
the cancer cells and their environments. Longitudinal studies will make it possible to model 
the dynamics of these changes in many dimensions. We imagine it will be feasible to 
associate the dynamics of omics measurements and imaging with clinical outcomes for a 
large population of patients, when machine-readable electronic medical records are adopted 
on a large scale. To support clinical decision making, we will need algorithms that can 
handle high-dimensional data and that provide interpretable results.
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Laura L. Kiessling: The surface of every cell is coated with glycans (glycoproteins, 
glycolipids and polysaccharides) that serve as the ‘face’ of the cell, reflecting its identity and 
state. In humans, glycans are critical for distinguishing foreign from self (for example, 
microbial versus human cells) and diseased from healthy cells. Still, we cannot yet 
determine a cell’s glycome. We must develop technologies that sensitively and accurately 
identify and sequence glycans. New methods to elucidate the relationship between genomic 
data and cell-surface glycans could transform our understanding of human health and 
disease. Such tools would also illuminate the basis for cell interactions in tissues, host–
microorganism interactions and mixed biological communities.
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Benjamin P. Kleinstiver: The unrelenting growth of the ‘CRISPR toolbox’ has 
fundamentally altered the type and scale of biological questions that the research and 
therapeutic communities can ask. Our ability to edit DNA sequences in virtually any 
organism has given humanity the technologies necessary to study life and potentially cure 
disease. We eagerly await answers from the first CRISPR-containing human clinical trials 
that utilize genome editing to augment immune-oncology and to treat inherited genetic 
diseases of the eye, blood, muscle and liver. Pending results that may motivate further 
tweaks and improvements to the technologies, the community may not need to ask what we 
cannot do with CRISPR for much longer, but instead might more seriously contemplate 
what we should not do.
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Credit: David Ahntholz
Rob Knight: The metagenomics community is poised to make three major advances. First, 
an accumulation of reference genomes (especially metagenome-assembled genomes) will 
make reference-mapping increasingly feasible for a wide range of environments, allowing 
easier estimation of which genomes are in each environment, and at what abundance, from 
cheap, short-read data. Second, an integration of genomic with chemical data (for example, 
short-chain fatty acids and other metabolites), especially in perturbation experiments, will 
greatly accelerate our understanding of which microorganisms produced which molecules. 
Third, improved tools for spatial mapping will enable visual analytics and deep learning of 
microorganism–molecule interactions, and improve our understanding of how 
microorganisms and their products exchange between hosts and environments.
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Philipp Kukura: Single-molecule methods have had a significant impact on the life 
sciences, ranging from imaging and structure determination to DNA sequencing. A central 
challenge for the field is applicability: transforming techniques used by specialists 
answering specific questions into those that are universally usable. There is something 
genuinely unique about being able to watch single molecules come together in space and 
time: the resulting images and movies directly reveal the mechanisms we draw when we try 
to conceptualise complex biomolecular processes. Key will be to connect the universality of 
our diagrams with the applicability of our technologies to enable the next generation of 
breakthroughs in the life sciences.
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Credit: MRC, Laboratory of Molecular Biology
Madeline A. Lancaster: The human brain, one of the final frontiers of exploration, still 
remains largely a mystery. How does such an otherwise indiscriminate lump of protoplasm 
carry out advanced human cognition? Brain organoids (models of the developing human 
brain) are now allowing us to embark on a new age of discovery in neuroscience. The next 
5–10 years will see a rapid succession of human neurological conditions modelled with this 
highly relevant and tractable system. In the long run, advancements in vascularisation and 
functional connectivity will push this technology further, and have the potential to answer an 
age-old question: what makes us human?
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Nicholas Loman: Recent advances in nanopore sequencing, combined with re-discovery of 
classical DNA extraction techniques and the gentlest of pipetting, have permitted ultra-long 
reads (over 100 kb and up to 2.3 megabases) to be generated from cell lines. This technique 
recently permitted the first telomere-to-telomere assembly of a human chromosome. The 
next big challenge is to make this approach applicable to human clinical samples containing 
much smaller amounts of DNA, and to find creative bioinformatics approaches that rapidly 
generate robust de novo genome assemblies and enable clinical interpretation both for 
human genomes and the microbiome! We are trying to tackle these problems as part of a 
global collaboration, so please join our Long Read Club.
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Credit: Matthew Staley, Janelia Research Campus
Loren Looger: Much progress has been made in the activation or silencing of genetically 
defined populations of cells with light, drugs, heat and sound. Methods for the control of 
specific proteins lag far behind. Ideally, techniques would: be at the protein, not nucleic acid, 
level; be essentially instantaneous and easily reversible; function on endogenous, not over-
expressed, protein; not disrupt function in the unstimulated state; and work in living animals 
and plants. For instance, the instantaneous, reversible ablation of a single transcription factor 
or receptor in genetically defined cells (or sub-cellular compartments) would reveal its 
contributions to cellular function and animal behavior in unprecedented detail.
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Credit: Markus Marcetic
Emma Lundberg: Measuring the expression of biomolecules in space and time at the single 
cell level will deepen our understanding of cell identity. Such studies of RNAs, proteins, 
lipids and metabolites are becoming increasingly feasible with advanced imaging, 
sequencing and mass spectrometry platforms. Exciting methodological challenges include 
the development of computational models of cells that integrate molecular and spatial 
information, and can represent cells as the dynamic and complex systems they are. Such 
single cell omics methods and computational cellular models have the potential to 
revolutionize our understanding of the normal states of human cells and trajectories into 
disease. By tuning the models to represent any cellular state, we should be able to infer the 
concerted changes that allow cells to perform their functions.
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Qingming Luo: Our knowledge of neuroscience is based on comprehensive identification 
and characterization of distinct neurons and neuronal circuits. Obtaining brain-wide 
mammalian brain atlases at single-neuron resolution with identified neuron morphology and 
entire neuronal circuits containing long projections is still challenging and requires the 
development of wide-field imaging techniques with high throughput and high voxel 
resolution, as well as intelligent high-throughput mass data processing techniques. Once we 
retrieve the entire set of projections of specific neuronal circuits as well as the affiliated 
functionally defined brain areas (which we call brainsmatics), it will be exciting to unravel 
mysteries such as the mechanisms of consciousness, dreams and cognition. Those 
discoveries will benefit our understanding of and development of therapy strategies for 
neurological disorders.
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Credit: RIKEN CBS
Atsushi Miyawaki: The introduction of functional probes may lead to either the up- or 
down-regulation of downstream intracellular signaling, and may perturb the cells we 
observe. Moreover, even with knock-in methods for probe introduction, a substantial amount 
of light or chemicals are absorbed by cells labeled with fluorescent or bioluminescent 
probes, respectively. Quantitative bio-imaging is expected to provide a methodological 
framework for simulating observation-dependent perturbation. Once we accept the idea that 
‘seeing is perturbing’, the visualization process will be regarded as a reaction towards 
objects, and our research efforts will lead us closer to real understanding. It is time to 
evaluate the assets of bio-imaging for their potential and limitations to truly benefit from this 
relatively new technology.
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Eugene W. Myers Jr: In genome sequencing, improvements in technology and computer 
algorithms will soon allow us to perfectly sequence a complex, multi-gigabase genome de 
novo at a modest price point, US$1,000 or less. This will herald an unprecedented 
exploration of ecosystems and the evolution of life. Many technical and methodological 
challenges must first be solved. In microscopy, microscopes are becoming increasingly 
programmable, and ‘smart’ devices and computational methods such as deep neural nets are 
enabling us to see further and more clearly into biological samples. A key challenge is to 
fully harness the power of adaptive optics, particularly in devices and samples where the use 
of fiducial markers and explicit measurement of the wave front are not possible.
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Garry P. Nolan: Single-cell phenotyping is moving towards generating tissue atlases and 
trekking inward towards establishing a 3D map of a cell’s constituents, simultaneously 
driving algorithmic development that enables mere humans to understand biology. The 
limitations of current marker technologies, including antibodies, chemical tags and gene 
fusions, beg the question of how do we measure everything? Inevitably, we need every 
atom’s position and identity, and from that atom cloud reconstruct the identities and 
positions of all cellular constituents. We are developing the concepts behind such an 
instrument to determine the positions of every atom in situ at sub-Ångstrom resolution. The 
field has spent so much time inferring, indirectly, a cell’s interior structure; why not just take 
a picture?
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Credit: Kaska Nowak
Paola Picotti: Proteomics can measure changes in the abundances of proteins for almost 
complete proteomes. However, a variety of molecular events can profoundly alter protein 
function without affecting protein levels. A key challenge for the future will be to find ways 
to simultaneously monitor all these events and thus provide a comprehensive picture of 
protein states. Protein structures integrate molecular cues such as chemical modification, 
conformational change, interaction with other molecules and cleavage, which all affect 
protein function. I propose that detecting protein structural changes on a global scale by 
mass spectrometry will provide novel ways to comprehensively detect protein functional 
changes, capture physiological and pathological alterations, and generate mechanistic 
hypotheses.
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Wolf Reik: We are witnessing an enormous revolution in single-cell genomics, which is 
being applied to millions of cells and giving rise to a new anatomy of the human body 
through the Human Cell Atlas and Human Developmental Biology initiatives. But there are 
many more layers of molecular information we can capture now and in the future in single 
cells, combining the transcriptome with DNA modifications and chromatin accessibility, 
histone marks and perhaps the proteome as well. An integration of time as a dimension in 
these measurements would be particularly exciting. Powerful machine-learning algorithms 
will connect these layers together and will be able to detect cell fate decisions, or cell fate 
change in disease, at an unprecedented level of precision. Eventually, single-cell editing may 
allow pathological changes in cell fate to be corrected, although this may take a little while 
yet.
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Markus Sauer: Super-resolution microscopy methods can provide spatial resolution that is 
well below the diffraction-limit of light microscopy, but they do not yet provide the 
molecular resolution required to understand how a cell functions and which mechanisms 
occur in the case of a dysfunction or disease. I anticipate that within the next years, 
combinations of methods such as expansion and super-resolution microscopy, supported by 
the development of intelligent dyes and labeling methods with minimal linkage error, will 
provide imaging of organelles and protein complexes with one to two nanometer resolution. 
By harnessing these tools, the future will allow us to decipher how nature encodes function 
at the molecular level.
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Credit: Juliana Sohn
Alex K. Shalek: Single-cell RNA-seq has transformed our ability to dissect cellular 
systems, enabling transcriptome-wide identification of cellular components and their 
molecular signatures. Yet, we still need to do more, such as: faithfully capture cell states at 
scale to decipher critical molecular attributes; comprehensively appreciate what a 
‘transcriptional snapshot’ can actually tell us about a cell’s past, present and future within a 
tissue; and systematically uncover the value derived from collecting and integrating 
additional data (for example, spatial position, dynamics, other omics, existing single-cell 
datasets, reference gene signatures and perturbations). Equally important, we must also 
empower global participation in the generation and analysis of these data to achieve broad 
mechanistic insights into human health and disease.
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Jay Shendure: This is a very exciting time for high-throughput functional genomic screens. 
The growing CRISPR toolset is enabling increasingly versatile experiments, for example, 
expanding the ‘targetable genome’ to noncoding regions. In my view, the primary challenge 
of the moment lies with expanding the range of phenotypes that are compatible with such 
screens beyond the typical ‘growth rate’ experiments. This includes, but is not limited to, 
whole transcriptional or epigenetic profiling, as well as imagingbased phenotyping, in 
association with each perturbation. Further challenges include achieving comprehensive 
pairwise interaction screens and moving functional genomic screens in vivo. Encouraging 
proof-of-concepts have recently been described for at least some of these goals.
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Nikolai Slavov: Recently, mass-spectrometry methods have increased the specificity and 
throughput of quantifying proteins in single mammalian cells: we can now quantify 
thousands of proteins across hundreds of single cells. I am confident that soon we will 
extend these methods to quantifying metabolites, post-translational modifications, and the 
dynamics and spatial distributions of proteins and their complexes. Ultimately, the accuracy, 
completeness and throughput of these measurements will provide data for transitioning from 
descriptive classification of single cells to quantitative models of regulatory protein 
interactions. I believe these data and models will enable systematic inference of direct causal 
mechanisms that underpin biological functions.
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Amos Tanay: Epigenomics is moving toward single-cell resolution and is already 
facilitating unprecedentedly sharp descriptive analysis of multiple epigenetic scales, ranging 
from DNA methylation, through decorated nucleosomes, up to chromosomal topologies. But 
epigenetics regulates genes by changing their physical contexts rather than turning them on 
and off in a digital fashion. Understanding all its scales and layers, therefore, requires truly 
quantitative models that are based on millions of single-cell epigenomic profiles. Such 
models must go significantly beyond black-box machine-learning predictions. We will have 
to learn to use the new data to develop principled and interpretable tools, with a clear multi-
scale biophysical basis that can match the multi-scale biology of the genome and its 
regulation.
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Olga Troyanskaya: With the broad availability of whole genome sequencing, the promise 
of precision medicine relies on the comprehensive interpretation of these genomes. Recently, 
deep learning models enabled the prediction of regulatory effects for many genetic variants. 
In the next decade, the challenge will be to integrate regulatory and coding variant effects 
across the whole genome to holistically predict phenotypic consequences for patients. This 
requires advances in modeling approaches as well as improved algorithmic efficiency, 
scalability and model interpretation. Critically, all progress relies on continued generation 
and sharing of experimental and clinical data. Integrative whole genome interpretation will 
deepen our understanding of genetics and can transform our ability to precisely diagnose and 
treat diverse diseases.
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David van Valen: The intersection of deep learning and biology is a very exciting space, 
particularly for those of us who work with biological images, as these methods are starting 
to provide robust solutions to long-standing problems such as image restoration, image 
segmentation and object tracking. To me, the most exciting aspect of this area is seeing the 
creative ways biologists are incorporating deep learning throughout their experimental 
designs and analytics pipelines. As deep learning methods become more commonplace, I 
think we are going to see a drastic increase in the pace of biological discovery.
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Hong-Wei Wang: Cryo-EM uses transmission electron microscopy to study frozen-
hydrated specimens at liquid nitrogen temperature to reveal the structures of 
macromolecules or cellular organelles in their relatively close-to-native states. The recent 
hardware and software breakthroughs in cryo-EM technology have transformed structural 
biology to a new phase, where macromolecule structure can be more robustly elucidated at 
near-atomic resolution. Instrumentation and computational developments of cryo-EM 
methods in the next decade will aim to solve structures at resolutions close to 1 Ångstrom, 
deciphering the dynamic conformational landscapes of macromolecules during reactions, 
revealing high-resolution molecular structures in situ, and directly correlating structures with 
functions in a broader cellular context.
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Chengqi Yi: Epitranscriptomic sequencing technologies that enable transcriptome-wide 
mapping of RNA modifications have added valuable knowledge about the role and 
regulation of RNA. Yet, there is an unmet biological need to quantify the absolute 
stoichiometry of the epitranscriptome. In addition, robust and sensitive methods that are 
highly reproducible and can serve as the gold standard of detection are still lacking for the 
majority of RNA modifications. Tools to specifically manipulate epitranscriptomic marks in 
spatially and temporally controlled manners are also urgently needed. Future challenges and 
exciting opportunities include epitranscriptome analysis at the single-cell and single-
molecule level, and in situ via the combination of sequencing and imaging.
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Peng Yin: DNA nanotechnology enables precise engineering of nanostrucures with user-
prescribed structural and dynamic properties, and has recently advanced diverse bioimaging 
approaches by providing enhanced resolution, signal amplification and multiplexing 
abilities, as well as methods in biosensing and single-molecule biophysics. More 
sophisticated nanodevices that perform in situ analysis of the molecular environment to 
generate real-time signal or action, or to encode spatial temporal features in DNA records, 
are particularly exciting for future development. Dare we even imagine molecular robots that 
survey an otherwise inaccessible molecular landscape, in a similar spirit as Web crawlers 
that index the internet or Mars rovers that inspect the planetary surface?
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Magdalena Zernicka-Goetz: One of the most interesting challenges in my field would be 
to uncover the principles by which the embryo builds itself so that we can create embryo 
models from cultured stem cells. Such models, if successful, would provide powerful tools 
to understand the complexity of intrinsic interactions between the cells that are essential for 
the embryo-building process, with its distinct organs, as well as uncover how developmental 
defects arise and how we can prevent them. Of course, such research has to be bounded and 
guided by ethical considerations.
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Xiaowei Zhuang: With recent advances in imaging and genomics technologies, it is truly 
exciting to envision the possibility of two previously seemingly unreachable goals. The first 
is to generate a full census and atlas of cells for living organisms, including human beings. 
Although the scale may seem daunting — a human is made of tens of trillions of cells — the 
rapid development of single-cell omics methods, including image-based single-cell 
transcriptomics, will allow this goal to be achieved in the foreseeable future. The second is 
to generate a full molecular architecture of the cell. The advent of super-resolution imaging 
and genomic-scale imaging has led us closer to realizing this ambition, though major 
challenges still lie ahead, making this a longer-term goal.
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